Additionally, three extra gene sets including the “unsaturated fatty acids”, “Acyl-CoA biosynthesis” and “NASH” were now also significantly enriched in the patients harbouring mutations in both genes (RNF43 and ZNRF3 group) (Fig. 7d). Here, RNF43 is linked to metabolic dysfunction-associated steatohepatitis.